SEC Form 4 research
| Issuer | Kymera Therapeutics, Inc. |
|---|---|
| Tickers | KYMR |
| Reporting owners | 48 |
| Officers and directors | 18 |
| Last public filing | 2026-10-01 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-10-01 | Mainolfi Nello | S | 262 | $116.12 | Not reported |
| 2026-10-01 | 2026-10-01 | Mainolfi Nello | S | 8,230 | $115.4 | Not reported |
| 2026-10-01 | 2026-10-01 | Mainolfi Nello | S | 7,601 | $114.43 | Not reported |
| 2026-10-01 | 2026-10-01 | Mainolfi Nello | S | 4,876 | $113.24 | Not reported |
| 2026-10-01 | 2026-10-01 | Mainolfi Nello | S | 5,506 | $112.42 | Not reported |
| 2026-10-01 | 2026-10-01 | Mainolfi Nello | S | 3,525 | $111.44 | Not reported |
| 2026-09-04 | 2026-09-04 | Adams Brian | S | 2,137 | $117.57 | Not reported |
| 2026-09-04 | 2026-09-04 | Adams Brian | S | 3,025 | $116.81 | Not reported |
| 2026-09-04 | 2026-09-04 | Adams Brian | S | 1,209 | $115.55 | Not reported |
| 2026-07-27 | 2026-07-27 | Rooney Terence | A | 38,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.